EFG Asset Management Americas Corp. Buys 12,712 Shares of CME Group Inc. (NASDAQ:CME)

EFG Asset Management Americas Corp. raised its position in CME Group Inc. (NASDAQ:CME) by 44.2% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 41,477 shares of the financial services provider’s stock after buying an additional 12,712 shares during the period. CME Group comprises approximately 1.6% of EFG Asset Management Americas Corp.’s holdings, making the stock its 16th largest holding. EFG Asset Management Americas Corp.’s holdings in CME Group were worth $8,154,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. B. Riley Wealth Advisors Inc. lifted its holdings in CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after buying an additional 48 shares during the period. Capital Advisors Ltd. LLC lifted its stake in shares of CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares during the period. Lantz Financial LLC boosted its position in shares of CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after purchasing an additional 49 shares during the last quarter. Lester Murray Antman dba SimplyRich grew its stake in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares during the period. Finally, Greystone Financial Group LLC increased its holdings in CME Group by 1.6% in the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock valued at $691,000 after purchasing an additional 52 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the transaction, the director now owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Stock Up 0.5 %

Shares of CME traded up $1.12 during midday trading on Friday, hitting $220.50. The stock had a trading volume of 2,899,331 shares, compared to its average volume of 1,933,394. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $79.39 billion, a price-to-earnings ratio of 25.09, a price-to-earnings-growth ratio of 6.51 and a beta of 0.52. The company has a 50 day simple moving average of $203.51 and a two-hundred day simple moving average of $207.61. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period last year, the business earned $2.30 EPS. On average, analysts anticipate that CME Group Inc. will post 9.89 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be paid a $1.15 dividend. The ex-dividend date is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.09%. CME Group’s payout ratio is currently 52.33%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CME. Piper Sandler restated an “overweight” rating and set a $225.00 target price on shares of CME Group in a report on Tuesday, August 20th. Barclays lifted their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. JPMorgan Chase & Co. upped their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Keefe, Bruyette & Woods increased their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Finally, Bank of America lowered shares of CME Group from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $212.00 to $177.00 in a report on Tuesday. Four equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $209.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.